In one paragraphArticle in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Mikael SkurnikHuman Microbiome Research Program, Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0001-8791-9260 Rahime TetikDepartment Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany.
Muhammad Suleman QasimHuman Microbiome Research Program, Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0001-7579-574X Jana SachsenröderDepartment Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany.
Ralf DieckmannDepartment Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany.ORCID 0000-0002-1533-7496 Carlos G Leon-VelardeLaboratory Services Division, University of Guelph, Guelph, ON N1H 8J7, Canada.
Göran WidmalmArrhenius Laboratory, Department of Chemistry, Stockholm University, S-106 91 Stockholm, Sweden.ORCID 0000-0001-8303-4481 Eckhard StrauchDepartment Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany.ORCID 0000-0003-2494-0278 Arnab BhattacharjeeHuman Microbiome Research Program, Department of Bacteriology and Immunology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.ORCID 0000-0002-9613-7911 Funding
German Federal Institute for Risk Assessment project BfR_45-002Research Council of Finland 288701Swedish Research Council 2022 03014
6 · The paper itselfAbstract
Indexed as
BacteriophagesReceptors, Cell SurfaceYersinia enterocoliticaBacteriocinsMultigene FamilyProtein BindingViral Tail ProteinsBacteriocinsReceptors, Cell SurfaceViral Tail ProteinsAlphafold3bacteriophageCarbBuilderenterocoliticinphage tail fiberreceptor binding proteintailocinYersinia enterocolitica
Identifiers
PMID41902199
PMCPMC13030884
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390